Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan‐Niklas Eckardt, Jan Moritz Middeke, Cristina M. Sauerland et al.|Haematologica|2022Cited by 47
Differential impact of <i>IDH1</i>/<i>2</i> mutational subclasses on outcome in adult AML: results from a large multicenter studyJan Moritz Middeke, Christian Thiede, Klaus H. Metzeler et al.|Blood Advances|2021Cited by 44
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classificationJan‐Niklas Eckardt, Christoph Röllig, Marius Bill et al.|Leukemia|2023Cited by 36
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcomeJulia-Annabell Georgi, Sebastian Stasik, Jan‐Niklas Eckardt et al.|Blood Cancer Journal|2023Cited by 19
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profilesJan‐Niklas Eckardt, Jan Moritz Middeke, Christoph Röllig et al.|Communications Medicine|2023Cited by 18